| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/08/2001 | CA2383557A1 Vaccine antigens of moraxella |
| 03/08/2001 | CA2383015A1 Antibodies specific for fullerenes |
| 03/08/2001 | CA2382953A1 Dna encoding the human serine protease c-e |
| 03/08/2001 | CA2382100A1 Dosages for treatment with anti-erbb2 antibodies |
| 03/08/2001 | CA2382026A1 Vaccine to control equine protozoal myeloencephalitis in horses |
| 03/08/2001 | CA2381901A1 A plant lecithin:cholesterol acyltransferase-like polypeptide |
| 03/08/2001 | CA2381451A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | CA2380355A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/07/2001 | EP1081226A1 Apoptin-associating protein |
| 03/07/2001 | EP1081224A1 Novel method for isolating gene |
| 03/07/2001 | EP1081222A1 Antibodies and utilization thereof |
| 03/07/2001 | EP1080371A1 Method and means for caries prevention and susceptibility detection |
| 03/07/2001 | EP1080233A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| 03/07/2001 | EP1080232A2 MarA FAMILY HELIX-TURN-HELIX DOMAINS AND THEIR METHODS OF USE |
| 03/07/2001 | EP1080203A2 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
| 03/07/2001 | EP1080199A2 (hemorrhagic enteritis) virus dna sequences, proteins encoded thereby and various uses thereof |
| 03/07/2001 | EP1080198A2 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 03/07/2001 | EP1080195A1 Endometriosis-associated gene |
| 03/07/2001 | EP1080194A2 Human transmembrane proteins |
| 03/07/2001 | EP1080190A1 Calmodulin related protein |
| 03/07/2001 | EP1080188A2 Human nucleic acid sequences of uterus myoma tissue |
| 03/07/2001 | EP1080185A2 Myelin basic protein peptides and uses thereof |
| 03/07/2001 | EP1080181A1 clpX OF STREPTOCOCCUS PNEUMONIAE |
| 03/07/2001 | EP1080113A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases |
| 03/07/2001 | EP1080112A1 Method for separating and/or isolating plasma proteins by annularchromatography |
| 03/07/2001 | EP1080111A2 The induction of antiobiotic peptides by lait (scd14) protein |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1079862A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 03/07/2001 | EP1079860A1 Nicotine immunogen |
| 03/07/2001 | EP1079856A1 Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 03/07/2001 | EP1079849A2 Use of hmg proteins for the preparation of medicaments having cytotoxic activity |
| 03/07/2001 | EP1079848A1 Angiostatin receptor |
| 03/07/2001 | EP1079847A2 Osteoporosis treatment |
| 03/07/2001 | EP1079843A2 USE OF g(a)1 g(b) INTEGRIN RECEPTOR INHIBITORS AND TGF- g(b)1 INHIBITORS IN THE TREATMENT OF KIDNEY DISEASE |
| 03/07/2001 | EP1079688A1 Method for expanding primate b cells selectively in immunocompromised mice and producing large numbers of antigen-specific b lymphocytes for the production of primate monoclonal antibodies |
| 03/07/2001 | EP0843591B1 Polyvinyl alcohol-based magnetic polymer particles, methods for their preparation and their use |
| 03/07/2001 | EP0587636B1 Fish vaccine for aeromonas salmonicida infection |
| 03/07/2001 | EP0486526B2 Tumour necrosis factor binding ligands |
| 03/07/2001 | CN1286727A Neisserial antigens |
| 03/07/2001 | CN1062908C Polypeptides and DNAs encoding them |
| 03/07/2001 | CN1062907C Method for preparation of antibody materials |
| 03/06/2001 | US6197940 Method for evaluating and affecting male fertility |
| 03/06/2001 | US6197939 Polypeptide regulator; for use as a diagnostic tool in detection of tumors |
| 03/06/2001 | US6197938 Monoclonal antibody specific for 20K human growth hormone and a cell line producing the monoclonal antibody |
| 03/06/2001 | US6197937 Antibody which preferentially binds mammalian binding protein; for the treatment of atherosclerosis |
| 03/06/2001 | US6197933 Human EP3, prostaglandin receptor |
| 03/06/2001 | US6197931 Human marco scavenger receptor |
| 03/06/2001 | US6197930 Polypeptide for use in organ preservation, cryopreservation, for surgical pretreatment to prevent injury due to inflammation; antiischemic agents |
| 03/06/2001 | US6197591 Nucleotide sequence which control the transcription of a preferential antibiotic |
| 03/06/2001 | US6197582 Development of human monoclonal antibodies and uses thereof |
| 03/06/2001 | US6197581 Human adenylate cyclase and use therefor |
| 03/06/2001 | US6197578 Cells expressing both human CD4 and a human fusion accessory factor associated with HIV infection |
| 03/06/2001 | US6197551 Spoil-1 protein and nucleic acid molecules and uses therefor |
| 03/06/2001 | US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina |
| 03/06/2001 | US6197533 Minimizing interference in immunoassay of serum sample by chemically modifying arginine, histidine, lysine, threonine, or tyrosine located in active site of antibody, antigen, or fragment |
| 03/06/2001 | US6197528 Composition of immunotoxins and retinoids and use thereof |
| 03/06/2001 | US6197525 Kit for detection of interleukin-17, interleukin-17 receptor, antagonists, or mimetics; includes receptor protein of defined amino acid sequence and a detecting reagent; for identifying immunosuppressants |
| 03/06/2001 | US6197524 Methods for detecting, identifying, isolating, and selectively labelling and targeting TH1 lymphocyte by means of the LAG-3 protein |
| 03/06/2001 | US6197519 Pancreas-derived serpin |
| 03/06/2001 | US6197511 Amino acid sequence; diagosis and treatment of cancer and skin disorders; anticarcinogenic agents; recombinant production; hybridization probes |
| 03/06/2001 | US6197500 For hybridization probes and amplification primers used to diagnose the presence or absence of a fragile x allele in an individual |
| 03/06/2001 | US6197496 Immunological reagents and diagnostic methods for the detection of human immunodeficiency virus type 2 utilizing multimeric forms of the envelope proteins gp300, p200, and p90/80 |
| 03/06/2001 | US6197313 Ryegrass pollen allergen |
| 03/06/2001 | US6197312 Surface antigen |
| 03/06/2001 | US6197310 Causative agent of the mystery swine disease, vaccine compositions and diagnostics kits |
| 03/06/2001 | US6197302 Administering fusion protein of major histocompatibility complex complexed to immunoglobulin constant domain |
| 03/06/2001 | US6197301 Compositions and methods for the prevention and diagnosis of Lyme disease |
| 03/06/2001 | US6197299 Target cell is contacted with a target cell lysis effective amount of a soluble monoclonal antibody or fragment conjugate covalently linked by peptide bond linkage to a superantigen for the lysis of a target cell by assistance of lymphocytes |
| 03/06/2001 | US6197297 Monoclonal antibody specific to polypeptide which induces interferon-gamma production |
| 03/06/2001 | US6197294 Cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by host cell by host immune system; useful for gene therapy |
| 03/06/2001 | US6197069 Adrenomedullin receptor polynucleotides |
| 03/06/2001 | CA1341199C Method for obtaining a vaccine with wide protective range against group b neisseria meningitidis, the resulting vaccine, gammaglobulin and transfer factor |
| 03/06/2001 | CA1341198C Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor |
| 03/01/2001 | WO2001014884A1 Melanoma associated antigen (hmw-maa) defined by a monoclonal antibody |
| 03/01/2001 | WO2001014881A1 Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-ms immune response |
| 03/01/2001 | WO2001014846A2 Methods and assay kits for detecting a pro-ms immune response via assay of b cells |
| 03/01/2001 | WO2001014564A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | WO2001014558A1 Human antibodies or fragments thereof binding to hla-cw6 |
| 03/01/2001 | WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor |
| 03/01/2001 | WO2001014556A1 Novel b7-4 molecules and uses therefor |
| 03/01/2001 | WO2001014554A1 G protein-coupled receptor expressed in brain |
| 03/01/2001 | WO2001014551A1 NOVEL bHLH TYPE TRANSCRIPTION FACTOR GENE DEC2 |
| 03/01/2001 | WO2001014549A1 Gas1 polypeptides |
| 03/01/2001 | WO2001014548A2 New g-protein coupled receptor and dna sequences thereof |
| 03/01/2001 | WO2001014547A1 Novel abc transporter and uses thereof |
| 03/01/2001 | WO2001014545A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 03/01/2001 | WO2001014535A2 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-β1,3-N-ACETYLGALACTOSAMINE-α-R/(GlcNAc to GalNAc) β1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3 |
| 03/01/2001 | WO2001014533A2 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 03/01/2001 | WO2001014528A1 Method of preparing immune response-inducing dendritic cells |
| 03/01/2001 | WO2001014424A2 Human ctla-4 antibodies and their uses |
| 03/01/2001 | WO2001014421A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 03/01/2001 | WO2001014415A2 Egfh2 genes and gene products |
| 03/01/2001 | WO2001014414A2 Human abc2 transporter and uses thereof |
| 03/01/2001 | WO2001014404A1 A polynucleotide encoding a human junctional adhesion protein (jam-2) |
| 03/01/2001 | WO2001013948A1 Outer membrane protein a, peptidoglycan-associated lipoprotein, and murein lipoprotein as therapeutic targets for treatment of sepsis |
| 03/01/2001 | WO2001013947A1 Reduction of the immunogenicity of non-human grafts |
| 03/01/2001 | WO2001013945A1 Methods and compositions for immunotherapy of b cell involvement in promotion of a disease condition comprising multiple sclerosis |
| 03/01/2001 | WO2001013944A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 03/01/2001 | WO2001013940A1 Hm1.24 antigen expression potentiators |